Risk of alterations in neurodevelopment in infants and preschool children with cancer
The risk of delay and lag in neurodevelopment is common in cancer patients under 5 years of age undergoing treatment. However, more studies are required to evaluate the effect of treatment on this group of patients as it may be affected by various factors.
Authors
- Alejandro G Gonzalez Garay (ORCID: https://orcid.org/0000-0003-2342-8539)
- Rocío Cárdenas-Cardos
- Alda García-Guzmán
- Marta Zapata‐Tarrés (ORCID: https://orcid.org/0000-0002-0737-924X)
- Antonio Rizzoli-Córdoba
- Liliana Velasco‐Hidalgo (ORCID: https://orcid.org/0000-0001-5882-2187)
- Roberto Rivera‐Luna
- Ana G. Ortiz-Razo
- Evereth A. Olmedo-Jiménez
- Kenya Shamira Carmona-Jaimez
Institutions
- Mexican Social Security Institute (MX)
- Hospital Infantil de México Federico Gómez (MX)
- Instituto Nacional de Pediatria (MX)
Publication Details
- Journal
- Boletín Médico del Hospital Infantil de México
- Published
- 2024-09-02
- DOI
- https://doi.org/10.24875/bmhim.24000011
- Primary Topic
- Cancer-related cognitive impairment studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Consejo Nacional de Ciencia y Tecnología